GILEAD Sciences has announced that combination drug Vosevi (sofosbuvir with velpatasvir and voxilaprevir), the first single tablet for the re-treatment of chronic hepatitis C infection in adults who have failed previous treatment with direct-acting antivirals, was added to the ARTG yesterday.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Mar 18
Warning: Undefined variable $flipbook_id in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1259
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
